Post-Surgical Rehabilitation of Dupuytren's Disease: A Retrospective Study

Authors

  • Carolina Pereira Barbeiro Centro de Medicina de Reabilitação de Alcoitão, Alcoitão, Portugal
  • Inês Mendes Ribeiro Hospital Fernando da Fonseca, Amadora, Portugal
  • André Ladeira Hospital Fernando da Fonseca, Amadora, Portugal
  • Ana Dias Hospital Fernando da Fonseca, Amadora, Portugal
  • Ana Cadete Hospital Fernando da Fonseca, Amadora, Portugal

DOI:

https://doi.org/10.25759/spmfr.252

Keywords:

Dupuytren Contracture/rehabilitation, Postoperative Care

Abstract

Introduction: Dupuytren’s disease is a benign proliferative connective tissue disorder that involves the hand’s palmar fascia. The first clinical signs reported by the patients are thickening near the MCP. The small finger is the most affected. Dupuytren’s disease is more common in men over 40 years old. Diabetes mellitus, alcohol use, smoking and HIV have all been associated with a higher risk of Dupuytren’s disease. Surgical intervention is the gold standard on Dupuytren’s treatment and is indicated in cases of advanced disease. Postoperative rehabilitation should start between 3 and 5 days with early range of motion and palmar shift.

Purpose: Characterize the post-operative population with Dupuytren’s disease and evaluate gains with the intervention of rehabilitation.

Method: Retrospective and descriptive longitudinal study using the clinical data of surgically treated patients with Dupuytren’s disease evaluated and treated according with a protocol of occupational therapy at our department. Results: From a total of 50 surgically treated patients, between January 2014 and August 2015, 92% were men. The average age was 64.22 years. Risk factors association was predominantly diabetes mellitus (22%), smoking (8%) and moderate to severe alcoholic habits (6%). A percentage of 54% were intervened in the right hand, and the majority of the patients were intervened in the 5th finger (38%). Forty two patients (84%) attended the sessions twice a week. Thirteen patients abandoned the treatment before the end. The treatment had an average length of 70.14 days (SD 42.5). In comparison between the beginning and the end of the rehabilitation program there were a significantly difference in the range of motion of the extension and flexion of the MCP (p = 0.00, p = 0.03) and PIP (p = 0.00, p = 0.01). Other statistical significant relations were not found

Discussion and Conclusion: Surgery followed by a structured rehabilitation program in Dupuytren’s disease allows an improvement in range of motion.

Downloads

Download data is not yet available.

References

Burge P. Genetics of Dupuytren’s disease. Hand Clin. 1999;15: 63-72.

Gudmundsson KG, Arngrimsson R, Sigfusson N, Bjornsson A, Jonsson T.

Epidemiology of Dupuytren’s disease:clinical, serological, and social

assessment. J Clin Epidemiol. 2000;53:291-6.

Karkampouna S, Kreulen M, Obdeijn MC, Kloen P, Dorjée, AL, Rivelles, F,

et al. Connective tissue degeneration: mechanisms of palmar fascia

degeneration (Dupuytren’s disease). Curr Mol Biol Rep. 2016;2:133-40.

Ross D. Epidemiology of Dupuytren’s disease. Hand Clin. 1999;15;53-62.

Saar JD, Grothaus PC. Dupuytren’s disease: an overview. Plast Reconstr

Surg. 2000;106:125-34.

Hart MG, Hooper G. Clinical associations of Dupuytren’s disease. Postgrad

Med J. 2005;81:425-8.

Murrell GA, Francis MJ, Bromley L. The collagen changes of Dupuytren’s

contracture. J Hand Surg Br. 1991;16:263-6.

McFarlane,RM, Botz FS, Cheung H. Dupuytren’s disease biology and

treatment. Edinburgh: Churchill Livingstone; 1990.

Lee H, Eo S, Cho S, Jones NF. The surgical release of Dupuytren’s

contracture using multiple transverse incisions. Arch Plast Surg.

;39;426-30.

Abe Y, Rokkaku T, Kuniyoshi K, Matsudo T, Yamada T. Clinical results of

dermofasciectomy for Dupuytren’s disease in Japanese patients. J Hand

Surg Eur Vol. 2007;32:407-10.

Dias JJ, Braybrooke J. Dupuytren’s contracture: an audit of the outcomes

of surgery. J Hand Surg Br. 2006;31:514-21.

Bayat A, McGrouther DA. Management of Dupuytren’s disease - clear

advice for an elusive condition. Ann R Coll Surg Engl. 2006;88:3-8.

Mullins PA. Postsurgical rehabilitation of Dupuytren’s disease. Hand Clin.

;15:167-74, viii.

Larson D, Jerosch-Herold C. Clinical effectiveness of post-operative

splinting after surgical release of Dupuytren’s contracture: a systematic

review. BMC Musculoskelet Disord. 2008 ;9:104.

Baird KS, Crossan JF, Ralston SH. Abnormal growth factor and cytokine

expression in Dupuytren’s contracture. J Clin Pathol. 1993;46:425-8.

Pratt AL, Ball C. What are we measuring? A critique of range of motion

methods currently in use for Dupuytren's disease and recommendations

for practice. BMC Musculoskelet Disord. 2016;17:20.

Eckerdal D, Nivestam A, Dahlin LB. Surgical treatment of Dupuytren’s

disease - outcome and health economy in relation to smoking and

diabetes. BMC Musculoskelet Disord. 2014;15:117.

Henry M. Dupuytren’s disease: current state of the art. Hand. 2014;9:1-8.

How to Cite

1.
Pereira Barbeiro C, Mendes Ribeiro I, Ladeira A, Dias A, Cadete A. Post-Surgical Rehabilitation of Dupuytren’s Disease: A Retrospective Study. SPMFR [Internet]. 2017 Aug. 5 [cited 2024 Nov. 22];29(1):22-6. Available from: https://spmfrjournal.org/index.php/spmfr/article/view/252

Issue

Section

Original Article

Similar Articles

<< < 

You may also start an advanced similarity search for this article.